Fujian Aonong Biological Technology Group Incorporation Ltd (603363) — Strategic Asset Allocation Index
Fujian Aonong Biological Technology Group Incorporation Ltd (603363) has a Strategic Asset Allocation Index of 452.3% as of June 2023. Strategic assets (PP&E of CN¥10.30 Billion plus long-term investments of CN¥-) total CN¥10.30 Billion, measured against net assets of CN¥2.28 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Fujian Aonong Biological Technology Grou liquidity resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Fujian Aonong Biological Technology Group Incorporation Ltd Strategic Asset Allocation Index (2015–2021)
This chart shows how Fujian Aonong Biological Technology Group Incorporation Ltd's Strategic Asset Allocation Index has evolved across 7 annual periods from 2015 to 2021. As of June 2023, the index stands at 452.3%, representing strategic assets of CN¥10.30 Billion against net assets of CN¥2.28 Billion CNY. See Fujian Aonong Biological Technology Grou free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Fujian Aonong Biological Technology Group Incorporation Ltd (2015–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Fujian Aonong Biological Technology Group Incorporation Ltd from 2015 to 2021, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 603363 market cap overview.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 488.1% | CN¥10.70 Billion | CN¥10.70 Billion | CN¥- | CN¥2.19 Billion | ▲ +317.4 pp |
| 2020 | 170.7% | CN¥6.66 Billion | CN¥6.66 Billion | CN¥- | CN¥3.90 Billion | ▼ -35.0 pp |
| 2019 | 205.7% | CN¥2.64 Billion | CN¥2.64 Billion | CN¥- | CN¥1.28 Billion | ▲ +48.1 pp |
| 2018 | 157.6% | CN¥1.59 Billion | CN¥1.59 Billion | CN¥- | CN¥1.01 Billion | ▲ +52.9 pp |
| 2017 | 104.7% | CN¥1.01 Billion | CN¥1.01 Billion | CN¥- | CN¥965.55 Million | ▼ -4.3 pp |
| 2016 | 108.9% | CN¥646.86 Million | CN¥646.86 Million | CN¥- | CN¥593.75 Million | ▲ +15.7 pp |
| 2015 | 93.2% | CN¥415.22 Million | CN¥415.22 Million | CN¥- | CN¥445.39 Million | — |